Placenta-derived exosomes: potential biomarkers of preeclampsia

Preeclampsia remains a leading cause of maternal and fetal mortality, due to ineffective treatment and diagnostic strategies, compounded by the lack of clarity on the etiology of the disorder. Although several clinical and biological markers of preeclampsia have been evaluated, they have proven to b...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of Nanomedicine 2017-01, Vol.12, p.8009-8023
Main Authors: Pillay, Preenan, Moodley, Kogi, Moodley, Jagidesa, Mackraj, Irene
Format: Article
Language:English
Subjects:
Biological markers
Biomarkers
Biomarkers - analysis
Blood pressure
Cancer
Cardiovascular disease
Care and treatment
Clinical medicine
Complications and side effects
Cytokines
Diagnosis
Etiology
Exosomes - pathology
Female
Fetuses
Health aspects
Humans
Hypertension
Laboratories
Medicine
Mortality
Pathogenesis
Placenta
Placenta - cytology
Placenta - pathology
Placental-derived exosomes
Pre-Eclampsia - diagnosis
Pre-Eclampsia - pathology
Preeclampsia
Pregnancy
Prognosis
Review
Risk factors
Stem cells
Veins & arteries
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c626t-8675bb371c2803a21de086fe1862f56b24adb3fdd4b9cbc30ac823dabdc5ace13
cites
container_end_page 8023
container_issue
container_start_page 8009
container_title International Journal of Nanomedicine
container_volume 12
creator Pillay, Preenan
Moodley, Kogi
Moodley, Jagidesa
Mackraj, Irene
description Preeclampsia remains a leading cause of maternal and fetal mortality, due to ineffective treatment and diagnostic strategies, compounded by the lack of clarity on the etiology of the disorder. Although several clinical and biological markers of preeclampsia have been evaluated, they have proven to be ineffective in providing a definitive diagnosis during the various stages of the disorder. Exosomes have emerged as ideal biomarkers of pathological states, such as cancer, and have more recently gained interest in pregnancy-related complications, due to their role in cellular communication in normal and complicated pregnancies. This occurs as a result of the specific placenta-derived exosomal molecular cargo, which may be involved in normal pregnancy-associated immunological events, such as the maintenance of maternal-fetal tolerance. This review provides perspectives on placenta-derived exosomes as possible biomarkers for the diagnosis/prognosis of preeclampsia. Using keywords, online databases were searched to identify relevant publications to review the potential use of placenta-derived exosomes as biomarkers of preeclampsia.
doi_str_mv 10.2147/IJN.S142732
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_575f90e13154402580ecfd5e7446d7b6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A532303347</galeid><doaj_id>oai_doaj_org_article_575f90e13154402580ecfd5e7446d7b6</doaj_id><sourcerecordid>A532303347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c626t-8675bb371c2803a21de086fe1862f56b24adb3fdd4b9cbc30ac823dabdc5ace13</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRAVLYUTdxSJCxLK4m8nHEBVRWFRBUjA2fLHePGSxMHOVvDv8Xa3pYuQD7Zm3ryZN35V9QSjBcFMvlx--Lj4ghmRlNyrTjCWbUMQpvfvvI-rhzmvEeKyFd2D6ph0uGUM4ZPqzedeWxhn3ThI4QpcDb9ijgPkV_UU55IJuq9NiINOPyDlOvp6SgC218OUg35UHXndZ3i8v0-rbxdvv56_by4_vVuen102VhAxN62Q3BgqsSUtoppgB6gVHnAriOfCEKadod45ZjprLEXatoQ6bZzlZT5MT6vljtdFvVZTCmWe3yrqoK4DMa2UTnOwPSguue9QqcG8aCS8RWC94yAZE04aUbhe77imjRnAbeUn3R-QHmbG8F2t4pXiQlLEUSF4vidI8ecG8qyGkC30vR4hbrLCnUREEsS2cz_7B7qOmzSWVSlCyg8QiTv-F7XSRUAYfSx97ZZUnXFKKKKUyYJa_AdVjoMh2DiCDyV-UPBiV2BTzDmBv9WIkdp6RxXvqL13Cvrp3bXcYm_MQv8AI9i9Uw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2240127195</pqid></control><display><type>article</type><title>Placenta-derived exosomes: potential biomarkers of preeclampsia</title><source>Publicly Available Content Database</source><source>Taylor &amp; Francis Journals Open Access</source><source>PubMed Central(OpenAccess)</source><creator>Pillay, Preenan ; Moodley, Kogi ; Moodley, Jagidesa ; Mackraj, Irene</creator><creatorcontrib>Pillay, Preenan ; Moodley, Kogi ; Moodley, Jagidesa ; Mackraj, Irene</creatorcontrib><description>Preeclampsia remains a leading cause of maternal and fetal mortality, due to ineffective treatment and diagnostic strategies, compounded by the lack of clarity on the etiology of the disorder. Although several clinical and biological markers of preeclampsia have been evaluated, they have proven to be ineffective in providing a definitive diagnosis during the various stages of the disorder. Exosomes have emerged as ideal biomarkers of pathological states, such as cancer, and have more recently gained interest in pregnancy-related complications, due to their role in cellular communication in normal and complicated pregnancies. This occurs as a result of the specific placenta-derived exosomal molecular cargo, which may be involved in normal pregnancy-associated immunological events, such as the maintenance of maternal-fetal tolerance. This review provides perspectives on placenta-derived exosomes as possible biomarkers for the diagnosis/prognosis of preeclampsia. Using keywords, online databases were searched to identify relevant publications to review the potential use of placenta-derived exosomes as biomarkers of preeclampsia.</description><identifier>ISSN: 1178-2013</identifier><identifier>ISSN: 1176-9114</identifier><identifier>EISSN: 1178-2013</identifier><identifier>DOI: 10.2147/IJN.S142732</identifier><identifier>PMID: 29184401</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Biological markers ; Biomarkers ; Biomarkers - analysis ; Blood pressure ; Cancer ; Cardiovascular disease ; Care and treatment ; Clinical medicine ; Complications and side effects ; Cytokines ; Diagnosis ; Etiology ; Exosomes - pathology ; Female ; Fetuses ; Health aspects ; Humans ; Hypertension ; Laboratories ; Medicine ; Mortality ; Pathogenesis ; Placenta ; Placenta - cytology ; Placenta - pathology ; Placental-derived exosomes ; Pre-Eclampsia - diagnosis ; Pre-Eclampsia - pathology ; Preeclampsia ; Pregnancy ; Prognosis ; Review ; Risk factors ; Stem cells ; Veins &amp; arteries</subject><ispartof>International Journal of Nanomedicine, 2017-01, Vol.12, p.8009-8023</ispartof><rights>COPYRIGHT 2017 Dove Medical Press Limited</rights><rights>2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Pillay et al. This work is published and licensed by Dove Medical Press Limited 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c626t-8675bb371c2803a21de086fe1862f56b24adb3fdd4b9cbc30ac823dabdc5ace13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2240127195/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2240127195?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,727,780,784,792,885,25753,27922,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29184401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pillay, Preenan</creatorcontrib><creatorcontrib>Moodley, Kogi</creatorcontrib><creatorcontrib>Moodley, Jagidesa</creatorcontrib><creatorcontrib>Mackraj, Irene</creatorcontrib><title>Placenta-derived exosomes: potential biomarkers of preeclampsia</title><title>International Journal of Nanomedicine</title><addtitle>Int J Nanomedicine</addtitle><description>Preeclampsia remains a leading cause of maternal and fetal mortality, due to ineffective treatment and diagnostic strategies, compounded by the lack of clarity on the etiology of the disorder. Although several clinical and biological markers of preeclampsia have been evaluated, they have proven to be ineffective in providing a definitive diagnosis during the various stages of the disorder. Exosomes have emerged as ideal biomarkers of pathological states, such as cancer, and have more recently gained interest in pregnancy-related complications, due to their role in cellular communication in normal and complicated pregnancies. This occurs as a result of the specific placenta-derived exosomal molecular cargo, which may be involved in normal pregnancy-associated immunological events, such as the maintenance of maternal-fetal tolerance. This review provides perspectives on placenta-derived exosomes as possible biomarkers for the diagnosis/prognosis of preeclampsia. Using keywords, online databases were searched to identify relevant publications to review the potential use of placenta-derived exosomes as biomarkers of preeclampsia.</description><subject>Biological markers</subject><subject>Biomarkers</subject><subject>Biomarkers - analysis</subject><subject>Blood pressure</subject><subject>Cancer</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Clinical medicine</subject><subject>Complications and side effects</subject><subject>Cytokines</subject><subject>Diagnosis</subject><subject>Etiology</subject><subject>Exosomes - pathology</subject><subject>Female</subject><subject>Fetuses</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Laboratories</subject><subject>Medicine</subject><subject>Mortality</subject><subject>Pathogenesis</subject><subject>Placenta</subject><subject>Placenta - cytology</subject><subject>Placenta - pathology</subject><subject>Placental-derived exosomes</subject><subject>Pre-Eclampsia - diagnosis</subject><subject>Pre-Eclampsia - pathology</subject><subject>Preeclampsia</subject><subject>Pregnancy</subject><subject>Prognosis</subject><subject>Review</subject><subject>Risk factors</subject><subject>Stem cells</subject><subject>Veins &amp; arteries</subject><issn>1178-2013</issn><issn>1176-9114</issn><issn>1178-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptUk1v1DAQjRAVLYUTdxSJCxLK4m8nHEBVRWFRBUjA2fLHePGSxMHOVvDv8Xa3pYuQD7Zm3ryZN35V9QSjBcFMvlx--Lj4ghmRlNyrTjCWbUMQpvfvvI-rhzmvEeKyFd2D6ph0uGUM4ZPqzedeWxhn3ThI4QpcDb9ijgPkV_UU55IJuq9NiINOPyDlOvp6SgC218OUg35UHXndZ3i8v0-rbxdvv56_by4_vVuen102VhAxN62Q3BgqsSUtoppgB6gVHnAriOfCEKadod45ZjprLEXatoQ6bZzlZT5MT6vljtdFvVZTCmWe3yrqoK4DMa2UTnOwPSguue9QqcG8aCS8RWC94yAZE04aUbhe77imjRnAbeUn3R-QHmbG8F2t4pXiQlLEUSF4vidI8ecG8qyGkC30vR4hbrLCnUREEsS2cz_7B7qOmzSWVSlCyg8QiTv-F7XSRUAYfSx97ZZUnXFKKKKUyYJa_AdVjoMh2DiCDyV-UPBiV2BTzDmBv9WIkdp6RxXvqL13Cvrp3bXcYm_MQv8AI9i9Uw</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Pillay, Preenan</creator><creator>Moodley, Kogi</creator><creator>Moodley, Jagidesa</creator><creator>Mackraj, Irene</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Placenta-derived exosomes: potential biomarkers of preeclampsia</title><author>Pillay, Preenan ; Moodley, Kogi ; Moodley, Jagidesa ; Mackraj, Irene</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c626t-8675bb371c2803a21de086fe1862f56b24adb3fdd4b9cbc30ac823dabdc5ace13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biological markers</topic><topic>Biomarkers</topic><topic>Biomarkers - analysis</topic><topic>Blood pressure</topic><topic>Cancer</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Clinical medicine</topic><topic>Complications and side effects</topic><topic>Cytokines</topic><topic>Diagnosis</topic><topic>Etiology</topic><topic>Exosomes - pathology</topic><topic>Female</topic><topic>Fetuses</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Laboratories</topic><topic>Medicine</topic><topic>Mortality</topic><topic>Pathogenesis</topic><topic>Placenta</topic><topic>Placenta - cytology</topic><topic>Placenta - pathology</topic><topic>Placental-derived exosomes</topic><topic>Pre-Eclampsia - diagnosis</topic><topic>Pre-Eclampsia - pathology</topic><topic>Preeclampsia</topic><topic>Pregnancy</topic><topic>Prognosis</topic><topic>Review</topic><topic>Risk factors</topic><topic>Stem cells</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pillay, Preenan</creatorcontrib><creatorcontrib>Moodley, Kogi</creatorcontrib><creatorcontrib>Moodley, Jagidesa</creatorcontrib><creatorcontrib>Mackraj, Irene</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International Journal of Nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pillay, Preenan</au><au>Moodley, Kogi</au><au>Moodley, Jagidesa</au><au>Mackraj, Irene</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Placenta-derived exosomes: potential biomarkers of preeclampsia</atitle><jtitle>International Journal of Nanomedicine</jtitle><addtitle>Int J Nanomedicine</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>12</volume><spage>8009</spage><epage>8023</epage><pages>8009-8023</pages><issn>1178-2013</issn><issn>1176-9114</issn><eissn>1178-2013</eissn><abstract>Preeclampsia remains a leading cause of maternal and fetal mortality, due to ineffective treatment and diagnostic strategies, compounded by the lack of clarity on the etiology of the disorder. Although several clinical and biological markers of preeclampsia have been evaluated, they have proven to be ineffective in providing a definitive diagnosis during the various stages of the disorder. Exosomes have emerged as ideal biomarkers of pathological states, such as cancer, and have more recently gained interest in pregnancy-related complications, due to their role in cellular communication in normal and complicated pregnancies. This occurs as a result of the specific placenta-derived exosomal molecular cargo, which may be involved in normal pregnancy-associated immunological events, such as the maintenance of maternal-fetal tolerance. This review provides perspectives on placenta-derived exosomes as possible biomarkers for the diagnosis/prognosis of preeclampsia. Using keywords, online databases were searched to identify relevant publications to review the potential use of placenta-derived exosomes as biomarkers of preeclampsia.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>29184401</pmid><doi>10.2147/IJN.S142732</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-2013
ispartof International Journal of Nanomedicine, 2017-01, Vol.12, p.8009-8023
issn 1178-2013
1176-9114
1178-2013
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_575f90e13154402580ecfd5e7446d7b6
source Publicly Available Content Database; Taylor & Francis Journals Open Access; PubMed Central(OpenAccess)
subjects Biological markers
Biomarkers
Biomarkers - analysis
Blood pressure
Cancer
Cardiovascular disease
Care and treatment
Clinical medicine
Complications and side effects
Cytokines
Diagnosis
Etiology
Exosomes - pathology
Female
Fetuses
Health aspects
Humans
Hypertension
Laboratories
Medicine
Mortality
Pathogenesis
Placenta
Placenta - cytology
Placenta - pathology
Placental-derived exosomes
Pre-Eclampsia - diagnosis
Pre-Eclampsia - pathology
Preeclampsia
Pregnancy
Prognosis
Review
Risk factors
Stem cells
Veins & arteries
title Placenta-derived exosomes: potential biomarkers of preeclampsia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A05%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Placenta-derived%20exosomes:%20potential%20biomarkers%20of%20preeclampsia&rft.jtitle=International%20Journal%20of%20Nanomedicine&rft.au=Pillay,%20Preenan&rft.date=2017-01-01&rft.volume=12&rft.spage=8009&rft.epage=8023&rft.pages=8009-8023&rft.issn=1178-2013&rft.eissn=1178-2013&rft_id=info:doi/10.2147/IJN.S142732&rft_dat=%3Cgale_doaj_%3EA532303347%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c626t-8675bb371c2803a21de086fe1862f56b24adb3fdd4b9cbc30ac823dabdc5ace13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2240127195&rft_id=info:pmid/29184401&rft_galeid=A532303347&rfr_iscdi=true